참고문헌
- ANDERSON, D. M., MARASKOVSKY, E., BILLINGSLEY, W. L., DOUGALL, W. C., TOMETSKO, M. E., ROUX, E. R., TEEPE, M. C., DUBOSE, R. F., COSMAN, D. and GALIBERT, L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-9, 1997 https://doi.org/10.1038/36593
- ASAGIRI, M., SATO, K., USAMI, T., OCHI, S., NISHINA, H., YOSHIDA, H., MORITA, I., WAGNER, E. F., MAK, T. W., SERFLING, E. and TAKAYANAGI, H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 202:1261-9, 2005 https://doi.org/10.1084/jem.20051150
- BENEZRA, R., DAVIS, R. L., LOCKSHON, D., TURNER, D. L. and WEINTRAUB, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:49-59, 1990 https://doi.org/10.1016/0092-8674(90)90214-Y
- BLANK, V. and ANDREWS, N. C. The Maf transcription factors: regulators of differentiation. Trends Biochem Sci. 22:437-41, 1997 https://doi.org/10.1016/S0968-0004(97)01105-5
- BOYLE, W. J., SIMONET, W. S. and LACEY, D. L. Osteoclast differentiation and activation. Nature. 423:337-42, 2003 https://doi.org/10.1038/nature01658
- CORDES, S. P. and BARSH, G. S. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell. 79:1025-34, 1994 https://doi.org/10.1016/0092-8674(94)90033-7
- EICHMANN, A., GRAPIN-BOTTON, A., KELLY, L., GRAF, T., LE DOUARIN, N. M. and SIEWEKE, M. The expression pattern of the mafB/kr gene in birds and mice reveals that the kreisler phenotype does not represent a null mutant. Mech Dev. 65:111-22, 1997 https://doi.org/10.1016/S0925-4773(97)00063-4
- HIROTANI, H., TUOHY, N. A., WOO, J. T., STERN, P. H. and CLIPSTONE, N. A. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem. 279:13984-92, 2004 https://doi.org/10.1074/jbc.M213067200
- HODGKINSON, C. A., MOORE, K. J., NAKAYAMA, A., STEINGRIMSSON, E., COPELAND, N. G., JENKINS, N. A. and ARNHEITER, H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 74: 395-404, 1993 https://doi.org/10.1016/0092-8674(93)90429-T
- IOTSOVA, V., CAAMANO, J., LOY, J., YANG, Y., LEWIN, A. and BRAVO, R. Osteopetrosis in mice lacking NFkappaB1 and NF-kappaB2. Nat Med. 3:1285-9, 1997 https://doi.org/10.1038/nm1197-1285
- ISHIKAWA, S., ARASE, N., SUENAGA, T., SAITA, Y., NODA, M., KURIYAMA, T., ARASE, H. and SAITO, T. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int Immunol. 16: 1019-25, 2004 https://doi.org/10.1093/intimm/dxh103
- KELLY, L. M., ENGLMEIER, U., LAFON, I., SIEWEKE, M. H. and GRAF, T. MafB is an inducer of monocytic differentiation. Embo J. 19:1987-97, 2000 https://doi.org/10.1093/emboj/19.9.1987
- KIM, K., KIM, J. H., LEE, J., JIN, H. M., KOOK, H., KIM, K. K., LEE, S. Y. and KIM, N. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. DOI 10.1182/blood-2006-09-048249, 2007
- KIM, K., KIM, J. H., LEE, J., JIN, H. M., LEE, S. H., FISHER, D. E., KOOK, H., KIM, K. K., CHOI, Y. and KIM, N. Nuclear factor of activated T cells c1 induces osteoclastassociated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 280:35209-16, 2005 https://doi.org/10.1074/jbc.M505815200
- KIM, N., TAKAMI, M., RHO, J., JOSIEN, R. and CHOI, Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med. 195:201-9, 2002 https://doi.org/10.1084/jem.20011681
- KIM, Y., SATO, K., ASAGIRI, M., MORITA, I., SOMA, K. and TAKAYANAGI, H. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem. 280:32905-13, 2005 https://doi.org/10.1074/jbc.M505820200
- KOGA, T., INUI, M., INOUE, K., KIM, S., SUEMATSU, A., KOBAYASHI, E., IWATA, T., OHNISHI, H., MATOZAKI, T., KODAMA, T., TANIGUCHI, T., TAKAYANAGI, H. and TAKAI, T. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 428:758-63, 2004 https://doi.org/10.1038/nature02444
- LACEY, D. L., TIMMS, E., TAN, H. L., KELLEY, M. J., DUNSTAN, C. R., BURGESS, T., ELLIOTT, R., COLOMBERO, A., ELLIOTT, G., SCULLY, S., HSU, H., SULLIVAN, J., HAWKINS, N., DAVY, E., CAPPARELLI, C., ELI, A., QIAN, Y. X., KAUFMAN, S., SAROSI, I., SHALHOUB, V., SENALDI, G., GUO, J., DELANEY, J. and BOYLE, W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93: 165-76, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
- LASORELLA, A., UO, T. and IAVARONE, A. Id proteins at the cross-road of development and cancer. Oncogene. 20:8326-33, 2001 https://doi.org/10.1038/sj.onc.1205093
- LEE, J., KIM, K., KIM, J. H., JIN, H. M., CHOI, H. K., LEE, S. H., KOOK, H., KIM, K. K., YOKOTA, Y., LEE, S. Y., CHOI, Y. and KIM, N. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 107:2686-93, 2006 https://doi.org/10.1182/blood-2005-07-2798
- LEE, Z. H. and KIM, H. H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 305:211-4, 2003 https://doi.org/10.1016/S0006-291X(03)00695-8
- LUCHIN, A., PURDOM, G., MURPHY, K., CLARK, M. Y., ANGEL, N., CASSADY, A. I., HUME, D. A. and OSTROWSKI, M. C. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res. 15:451-60, 2000 https://doi.org/10.1359/jbmr.2000.15.3.451
- LUCHIN, A., SUCHTING, S., MERSON, T., ROSOL, T. J., HUME, D. A., CASSADY, A. I. and OSTROWSKI, M. C. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem. 276: 36703-10, 2001 https://doi.org/10.1074/jbc.M106418200
- MANSKY, K. C., SANKAR, U., HAN, J. and OSTROWSKI, M. C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NFkappa B ligand signaling. J Biol Chem. 277:11077-83, 2002 https://doi.org/10.1074/jbc.M111696200
- MASSARI, M. E. and MURRE, C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 20:429-40, 2000 https://doi.org/10.1128/MCB.20.2.429-440.2000
- MERCK, E., GAILLARD, C., GORMAN, D. M., MONTEROJULIAN, F., DURAND, I., ZURAWSKI, S. M., MENETRIERCAUX, C., CARRA, G., LEBECQUE, S., TRINCHIERI, G. and BATES, E. E. OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells. Blood. 104:1386-95, 2004 https://doi.org/10.1182/blood-2004-03-0850
- MOCSAI, A., HUMPHREY, M. B., VAN ZIFFLE, J. A., HU, Y., BURGHARDT, A., SPUSTA, S. C., MAJUMDAR, S., LANIER, L. L., LOWELL, C. A. and NAKAMURA, M. C. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 101:6158-63, 2004
- MOTOHASHI, H., SHAVIT, J. A., IGARASHI, K., YAMAMOTO, M. and ENGEL, J. D. The world according to Maf. Nucleic Acids Res. 25:2953-59, 1997 https://doi.org/10.1093/nar/25.15.2953
- MOTYCKOVA, G., WEILBAECHER, K. N., HORSTMANN, M., RIEMAN, D. J., FISHER, D. Z. and FISHER, D. E. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A. 98:5798-803, 2001
- SIEWEKE, M. H., TEKOTTE, H., FRAMPTON, J. and GRAF, T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell. 85:49-60, 1996 https://doi.org/10.1016/S0092-8674(00)81081-8
- SIMON, M. C. PU.1 and hematopoiesis: lessons learned from gene targeting experiments. Semin Immunol. 10:111-8, 1998 https://doi.org/10.1006/smim.1998.0112
- SINGH, H., DEKOTER, R. P. and WALSH, J. C. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb Symp Quant Biol. 64:13-20, 1999
- SO, H., RHO, J., JEONG, D., PARK, R., FISHER, D. E., OSTROWSKI, M. C., CHOI, Y. and KIM, N. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem. 278:24209-16, 2003 https://doi.org/10.1074/jbc.M302940200
- SUDA, T., TAKAHASHI, N., UDAGAWA, N., JIMI, E., GILLESPIE, M. T. and MARTIN, T. J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 20:345-57, 1999 https://doi.org/10.1210/er.20.3.345
- TAKAYANAGI, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med. 83:170-9, 2005 https://doi.org/10.1007/s00109-004-0612-6
- TAKAYANAGI, H., KIM, S., KOGA, T., NISHINA, H., ISSHIKI, M., YOSHIDA, H., SAIURA, A., ISOBE, M., YOKOCHI, T., INOUE, J., WAGNER, E. F., MAK, T. W., KODAMA, T. and TANIGUCHI, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889-901, 2002 https://doi.org/10.1016/S1534-5807(02)00369-6
- TEITELBAUM, S. L. Bone resorption by osteoclasts. Science. 289:1504-8, 2000 https://doi.org/10.1126/science.289.5484.1504
- TEITELBAUM, S. L. and ROSS, F. P. Genetic regulation of osteoclast development and function. Nat Rev Genet. 4: 638-49, 2003 https://doi.org/10.1038/nrg1122
- WAGNER, E. F. and EFERL, R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 208:126-40, 2005 https://doi.org/10.1111/j.0105-2896.2005.00332.x
- WANG, Z. Q., OVITT, C., GRIGORIADIS, A. E., MOHLESTEINLEIN, U., RUTHER, U. and WAGNER, E. F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:741-5, 1992 https://doi.org/10.1038/360741a0
- WONG, B. R., RHO, J., ARRON, J., ROBINSON, E., ORLINICK, J., CHAO, M., KALACHIKOV, S., CAYANI, E., BARTLETT, F. S., 3RD, FRANKEL, W. N., LEE, S. Y. and CHOI, Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J Biol Chem. 272:25190-4, 1997 https://doi.org/10.1074/jbc.272.40.25190
- YASUDA, H., SHIMA, N., NAKAGAWA, N., YAMAGUCHI, K., KINOSAKI, M., MOCHIZUKI, S., TOMOYASU, A., YANO, K., GOTO, M., MURAKAMI, A., TSUDA, E., MORINAGA, T., HIGASHIO, K., UDAGAWA, N., TAKAHASHI, N. and SUDA, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 95:3597-602, 1998